SG10202100630SA - Combination test for colorectal cancer - Google Patents

Combination test for colorectal cancer

Info

Publication number
SG10202100630SA
SG10202100630SA SG10202100630SA SG10202100630SA SG10202100630SA SG 10202100630S A SG10202100630S A SG 10202100630SA SG 10202100630S A SG10202100630S A SG 10202100630SA SG 10202100630S A SG10202100630S A SG 10202100630SA SG 10202100630S A SG10202100630S A SG 10202100630SA
Authority
SG
Singapore
Prior art keywords
colorectal cancer
combination test
test
combination
colorectal
Prior art date
Application number
SG10202100630SA
Other languages
English (en)
Inventor
Jacob Vincent Micallef
Jason Terrell
Original Assignee
Belgian Volition Sprl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Belgian Volition Sprl filed Critical Belgian Volition Sprl
Publication of SG10202100630SA publication Critical patent/SG10202100630SA/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57419Specifically defined cancers of colon
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875Nucleoproteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721Haemoglobin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/70Mechanisms involved in disease identification

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
SG10202100630SA 2016-07-25 2017-07-25 Combination test for colorectal cancer SG10202100630SA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1612815.9A GB201612815D0 (en) 2016-07-25 2016-07-25 Novel combination test

Publications (1)

Publication Number Publication Date
SG10202100630SA true SG10202100630SA (en) 2021-03-30

Family

ID=56894403

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10202100630SA SG10202100630SA (en) 2016-07-25 2017-07-25 Combination test for colorectal cancer
SG11201900329XA SG11201900329XA (en) 2016-07-25 2017-07-25 Combination test for colorectal cancer

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201900329XA SG11201900329XA (en) 2016-07-25 2017-07-25 Combination test for colorectal cancer

Country Status (16)

Country Link
US (1) US20200182875A1 (ru)
EP (1) EP3488238B1 (ru)
JP (1) JP6983221B2 (ru)
KR (1) KR102442803B1 (ru)
CN (1) CN109791154A (ru)
AU (1) AU2017301970B2 (ru)
BR (1) BR112019001384A2 (ru)
CA (1) CA3031580A1 (ru)
GB (1) GB201612815D0 (ru)
IL (1) IL264359B2 (ru)
MY (1) MY193895A (ru)
RU (1) RU2019104870A (ru)
SG (2) SG10202100630SA (ru)
TW (1) TWI776816B (ru)
WO (1) WO2018019827A1 (ru)
ZA (1) ZA201808601B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021024009A1 (en) * 2019-08-02 2021-02-11 Shanghai Yunxiang Medical Technology Co., Ltd. Methods and compositions for providing colon cancer assessment using protein biomarkers
CN112345766B (zh) * 2020-10-22 2024-02-02 中国工程物理研究院核物理与化学研究所 一种荧光-放射性联用的体外靶向筛选方法
TW202242146A (zh) * 2021-01-13 2022-11-01 比利時商比利時意志有限公司 肺癌的檢測方法
EP4291899A1 (en) * 2021-02-11 2023-12-20 EDP Biotech Corporation Kits and methods for detecting markers and determining the presence or risk of cancer
CN116718775B (zh) * 2023-08-04 2023-10-27 天津迈基生物科技有限公司 一种检测结直肠癌的组合物、试纸及方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2394170T3 (en) * 2009-02-03 2015-07-13 Mdxhealth Sa Methods for detecting colorectal cancer
EP2419737A4 (en) * 2009-04-14 2013-02-13 Univ California HISTON MODIFYING PATTERN FOR CLINICAL DIAGNOSIS AND FORECASTING CANCER
US8568984B2 (en) * 2010-02-19 2013-10-29 Philadelphia Health & Education Corporation Methods of diagnosing non-urinary tract diseases by detecting aberrant methylation
JP2012018119A (ja) * 2010-07-09 2012-01-26 Toray Ind Inc 大腸癌検出用マーカーおよびそれを用いた大腸癌検出方法
CA2807440A1 (en) * 2010-08-04 2012-02-09 Cizzle Biotechnology Limited Methods and compounds for the diagnosis and treatment of cancer
GB201115098D0 (en) * 2011-09-01 2011-10-19 Belgian Volition Sa Method for detecting nucleosomes containing histone variants
ES2649404T3 (es) * 2011-12-07 2018-01-11 Belgian Volition Sprl Procedimiento para detectar aductos de nucleosomas
US11254985B2 (en) * 2012-05-11 2022-02-22 Clinical Genomics Pty. Ltd. Diagnostic gene marker panel for colorectal cancer

Also Published As

Publication number Publication date
RU2019104870A (ru) 2020-08-25
MY193895A (en) 2022-10-31
IL264359B1 (en) 2023-11-01
GB201612815D0 (en) 2016-09-07
SG11201900329XA (en) 2019-02-27
US20200182875A1 (en) 2020-06-11
RU2019104870A3 (ru) 2020-12-01
AU2017301970B2 (en) 2023-04-27
CN109791154A (zh) 2019-05-21
WO2018019827A1 (en) 2018-02-01
BR112019001384A2 (pt) 2019-04-30
IL264359B2 (en) 2024-03-01
ZA201808601B (en) 2019-09-25
IL264359A (en) 2019-02-28
JP2019527361A (ja) 2019-09-26
EP3488238C0 (en) 2023-06-07
AU2017301970A1 (en) 2019-01-17
CA3031580A1 (en) 2018-02-01
EP3488238B1 (en) 2023-06-07
JP6983221B2 (ja) 2021-12-17
TWI776816B (zh) 2022-09-11
KR102442803B1 (ko) 2022-09-15
EP3488238A1 (en) 2019-05-29
KR20190039089A (ko) 2019-04-10
TW201804156A (zh) 2018-02-01

Similar Documents

Publication Publication Date Title
DK3478217T3 (en) Historisk scanningsreference for intraorale scanninger
IL255217A0 (en) Cancer neo-epitopes
EP3189082A4 (en) Anti-pd-l1 conjugates for treating tumors
EP3166976A4 (en) Anti-pd-l1 combinations for treating tumors
IL280521A (en) Suspended markers for colon and rectal cancer
GB2545361B (en) Methods of assessing colorectal cancer status
GB201409479D0 (en) Molecular diagnostic test for cancer
SG11201610551TA (en) Combinations for treating cancers
IL264359A (en) Combined test for colon cancer
GB201613961D0 (en) Detector
GB201604075D0 (en) Detector
SG11201701875YA (en) Methods for detecting ovarian cancer
GB201500584D0 (en) Cancer biomarkers
GB201516524D0 (en) Detector
HK1231405A1 (zh) 篩選和檢測癌症的方法和組成
RS57326B1 (sr) Detektor
HK1249134A1 (zh) 結直腸癌相關疾病的生物標誌物
IL259661A (en) Biomarkers for cancer treatment with epilimod
IL257514A (en) A method for detecting cancer
SG11201702077RA (en) Kit for cancer detection
GB201508480D0 (en) Cancer
GB2546773B (en) Cancer
PL3305432T3 (pl) Środek kontrolny do zamykarki puszek
GB2552143B (en) Test Arrangement
GB2550120B (en) Probe